![Yohan Hazot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yohan Hazot
Profile
Yohan Hazot worked as the Chief Technology Officer at VYNE Pharmaceuticals Ltd.
from 2014 to 2017.
He graduated from the Institut National des Sciences Appliquées de Strasbourg.
Former positions of Yohan Hazot
Companies | Position | End |
---|---|---|
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Chief Tech/Sci/R&D Officer | 01/08/2017 |
Training of Yohan Hazot
Institut National des Sciences Appliquées de Strasbourg | Graduate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Yohan Hazot